One thing is for certain though – the pandemic is not over yet.
Academic rigour, journalistic flair
Articles on Coronavirus insights
Displaying 61 - 80 of 1079 articles
‘Tis the season… for coughs, colds and COVID, it seems. So what should you do if you find yourself with symptoms on Christmas Day?
In particular, a drug called Evusheld could offer protection for people who are vulnerable – but the UK isn’t offering it.
Reports from China indicate BF.7 is quicker to transmit and has greater capacity to escape prior immunity than other omicron subvariants. But we shouldn’t be alarmed at this stage.
We’re in a better position compared with 2020 and 2021, but the pandemic isn’t over yet.
There seems to be increased complacency around continued COVID infections, and even an attitude that they don’t matter. But they do – and we can reduce the risk.
The Chinese population has low immunity against COVID, making it vulnerable to high levels of transmission.
The good news is memory function may improve again over time.
This drug could essentially close the door to the virus, preventing it from getting into our cells.
We don’t have a lot of scientific evidence on how much additional protection a fourth dose would offer younger adults. But on balance, giving them the option could be worthwhile.
Nobody wants a case of COVID or flu as a take-home gift from their office Christmas party.
For one, washing your hands is unlikely to prevent COVID spread.
The risk of catching COVID at home wasn’t researched, advised on, legislated about, policed or managed as much as risk at work, school or in public places.
A UK survey found most long COVID sufferers have experienced discrimination, prejudice or shame related to the condition.
People who had COVID were 55% more likely to develop epilepsy or seizures over the next six months than people who had influenza – but the overall risk is still small.
Record numbers of young people have faced mental health difficulties during the pandemic. Our research suggests that those without computer access were more likely to be affected.
During the pandemic, online learning suddenly replaced traditional teaching methods.
Two new omicron variants seem to be waiting in the wings to usurp BA.5. Here’s what we know about BQ.1 and XBB.
Our research has shown that people with high blood pressure are more likely to be admitted to hospital and die from COVID. But effective blood pressure control helps.
Cases of seasonal diseases may be higher due to a lack of exposure during the pandemic. Here are four graphs which give us some clues as to how things might play out.
Supported by
Top contributors
-
Senior Research Fellow in Global Health, University of Southampton
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of East Anglia
-
Professor of Public Health, University of Sheffield
-
Lecturer in Psychology, Swansea University
-
Professor in Biomedical Sciences, University of Manchester
-
Professor of Mathematics and Statistics, University of Strathclyde
-
Associate Professor in Viral Immunology, University of Birmingham
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Research Fellow in Virology, University of Leeds
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Assistant Professor in Health Promotion and Policy, UMass Amherst, UMass Amherst
-
Professor of Primary Care Health Sciences, University of Oxford
